Journal of Vascular Surgery
Volume 48, Issue 1 , Pages 54-63 , July 2008

Thoracic aortic lesions treated with the Zenith TX1 and TX2 thoracic devices: Intermediate- and long-term outcomes

Presented at the Thirty-First Annual Meeting of the Southern Association for Vascular Surgery, Rio Grande, Puerto Rico, Jan 17-20, 2007.

  • Jose P. Morales, MD

      Affiliations

    • Department of Vascular and Endovascular Surgery, Cleveland, Ohio
  • ,
  • Roy K. Greenberg, MD

      Affiliations

    • Department of Vascular and Endovascular Surgery, Cleveland, Ohio
    • Department of Thoracic and Cardiovascular Surgery, Cleveland, Ohio
    • Corresponding Author InformationReprint requests: Roy K. Greenberg, MD, Cleveland Clinic, 9500 Euclid Ave, Desk S40, Cleveland, OH 44195.
  • ,
  • Catherine A. Morales, BS

      Affiliations

    • Department of Vascular and Endovascular Surgery, Cleveland, Ohio
  • ,
  • Marcelo Cury, MD

      Affiliations

    • Department of Vascular and Endovascular Surgery, Cleveland, Ohio
  • ,
  • Adrian V. Hernandez, MD, PhD

      Affiliations

    • Department of Quantitive Health Science, Cleveland Clinic, Cleveland, Ohio.
  • ,
  • Sean P. Lyden, MD

      Affiliations

    • Department of Vascular and Endovascular Surgery, Cleveland, Ohio
  • ,
  • Daniel Clair, MD

      Affiliations

    • Department of Vascular and Endovascular Surgery, Cleveland, Ohio

Received 24 October 2007 ,Accepted 15 February 2008.

  • Image Result

    Overall mortality (thick line) and aneurysm-related morality (thin line) were assessed using a Kaplan-Meier analysis, and the error bars denote the 95% confidence intervals (CI).

    Overall mortality (thick line) and aneurysm-related morality (thin line) were assessed using a Kaplan-Meier analysis, and the error bars denote the 95% confidence intervals (CI).

  • Image Result

    Freedom from secondary intervention is shown in 160 patients with >72 months of follow-up.

    Freedom from secondary intervention is shown in 160 patients with >72 months of follow-up.

  • Image Result

    A, Kaplan-Meier life-table analysis shows of freedom from primary endoleak and (B) secondary endoleaks.

    A, Kaplan-Meier life-table analysis shows of freedom from primary endoleak and (B) secondary endoleaks.

  • Image Result

    A, A three-dimensional (3D) reconstruction of a computed tomography (CT) scan demonstrates an endovascular completion of an elephant trunk graft. The pacer wire attached near the distal end of the ele

    A, A three-dimensional (3D) reconstruction of a computed tomography (CT) scan demonstrates an endovascular completion of an elephant trunk graft. The pacer wire attached near the distal end of the elephant trunk graft is indicated by the small arrow. Distally, the device was deployed into an aneurysmal segment that had been wrapped with a polyester strip to create a landing zone in a patient deemed unable to tolerate an open thoracoabdominal repair (large arrow). B, Same patient, 3D reconstruction CT scan at the 6-month follow-up demonstrates a stable proximal dense position (arrow) enlargement of the wrapped segment, distal endoleak, and proximal migration (circle) of the distal stent through the wrap and into the aneurysm. Note, no barbs were used on the distal fixation system for fear of injury to the abnormal aorta below the level of the stent graft. C, Magnified view of previous image demonstrates scratches on the external aortic wall (arrows) caused by migration of the device.

  • Image Result
    A and B, Radiographs in different projections demonstrate a single barb fracture (circle and arrow) first noticed at 2 years follow up.

    A and B, Radiographs in different projections demonstrate a single barb fracture (circle and arrow) first noticed at 2 years follow up.

 Competition of interest: Dr Greenberg receives grants and research support from Cook Inc, W. L. Gore & Assoc, and Terarecon, is a consultant for Cook Inc and Boston Scientific, and receives other financial or material support from Cook Inc, Intellectual Property. Dr Clair is a paid consultant for Cordis, an unpaid consultant for Timna and Minnow Medical, is a speaker for FoxHollow, Cook Inc, W. L. Gore & Assoc, and OmniSonics, and is an advisory board member for Medtronic and Boston Scientific. Dr Lyden is a consultant for Cook Inc.

PII: S0741-5214(08)00279-6

doi: 10.1016/j.jvs.2008.02.028

Journal of Vascular Surgery
Volume 48, Issue 1 , Pages 54-63 , July 2008